Form 4 for MRNA Moderna
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-15 · accession 0001127602-23-024257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | 2023-09-15 | MRNA | Bancel Stephane | CEO, Dir | J - Other | $0.00 | +17.9K | 5.43M | +0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | J | A | 17,893 | $0.00 | 5,429,839 | D | — | — |